Literature DB >> 19956594

Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept.

Cheng-Yeu Wu1, Jan Martel, David Young, John D Young.   

Abstract

Serum-derived granulations and purported nanobacteria (NB) are pleomorphic apatite structures shown to resemble calcium granules widely distributed in nature. They appear to be assembled through a dual inhibitory-seeding mechanism involving proteinaceous factors, as determined by protease (trypsin and chymotrypsin) and heat inactivation studies. When inoculated into cell culture medium, the purified proteins fetuin-A and albumin fail to induce mineralization, but they will readily combine with exogenously added calcium and phosphate, even in submillimolar amounts, to form complexes that will undergo morphological transitions from nanoparticles to spindles, films, and aggregates. As a mineralization inhibitor, fetuin-A is much more potent than albumin, and it will only seed particles at higher mineral-to-protein concentrations. Both proteins display a bell-shaped, dose-dependent relationship, indicative of the same dual inhibitory-seeding mechanism seen with whole serum. As ascertained by both seeding experiments and gel electrophoresis, fetuin-A is not only more dominant but it appears to compete avidly for nanoparticle binding at the expense of albumin. The nanoparticles formed in the presence of fetuin-A are smaller than their albumin counterparts, and they have a greater tendency to display a multi-layered ring morphology. In comparison, the particles seeded by albumin appear mostly incomplete, with single walls. Chemically, spectroscopically, and morphologically, the protein-mineral particles resemble closely serum granules and NB. These particles are thus seen to undergo an amorphous to crystalline transformation, the kinetics and completeness of which depend on the protein-to-mineral ratios, with low ratios favoring faster conversion to crystals. Our results point to a dual inhibitory-seeding, de-repression model for the assembly of particles in supersaturated solutions like serum. The presence of proteins and other inhibitory factors tend to block apatite nuclei formation or to stabilize the nascent nuclei as amorphous or semi-crystalline spherical nanoparticles, until the same inhibitory influences are overwhelmed or de-repressed, whereby the apatite nuclei grow in size to coalesce into crystalline spindles and films-a mechanism that may explain not only the formation of calcium granules in nature but also normal or ectopic calcification in the body.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19956594      PMCID: PMC2779105          DOI: 10.1371/journal.pone.0008058

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  197 in total

1.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins.

Authors:  G K Hunter; P V Hauschka; A R Poole; L C Rosenberg; H A Goldberg
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

2.  Electron diffraction from micro- and nanoparticles of hydroxyapatite.

Authors: 
Journal:  J Microsc       Date:  1999-10       Impact factor: 1.758

3.  Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals.

Authors:  R Fujisawa; Y Wada; Y Nodasaka; Y Kuboki
Journal:  Biochim Biophys Acta       Date:  1996-01-04

4.  Effect of ultrafilterable fragments from chondroitinase and protease-treated aggrecan on calcium phosphate precipitation in liposomal suspensions.

Authors:  E D Eanes; A W Hailer
Journal:  Calcif Tissue Int       Date:  1994-09       Impact factor: 4.333

Review 5.  Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles.

Authors:  Vivek Kumar; Gerard Farell; Shihui Yu; Sean Harrington; Lorraine Fitzpatrick; Ewa Rzewuska; Virginia M Miller; John C Lieske
Journal:  J Investig Med       Date:  2006-11       Impact factor: 2.895

6.  Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles.

Authors:  Alexander Heiss; Thomas Eckert; Anke Aretz; Walter Richtering; Wim van Dorp; Cora Schäfer; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

Review 7.  Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification.

Authors:  Willi Jahnen-Dechent; Cora Schäfer; Markus Ketteler; Marc D McKee
Journal:  J Mol Med (Berl)       Date:  2007-12-15       Impact factor: 4.599

8.  The inhibitory effect of cartilage proteoglycans on hydroxyapatite growth.

Authors:  C C Chen; A L Boskey; L C Rosenberg
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

Review 9.  Physiopathology and etiology of stone formation in the kidney and the urinary tract.

Authors:  Andrew P Evan
Journal:  Pediatr Nephrol       Date:  2009-02-07       Impact factor: 3.714

10.  Nanobacteria are mineralo fetuin complexes.

Authors:  Didier Raoult; Michel Drancourt; Saïd Azza; Claude Nappez; Régis Guieu; Jean-Marc Rolain; Patrick Fourquet; Bernard Campagna; Bernard La Scola; Jean-Louis Mege; Pascal Mansuelle; Eric Lechevalier; Yvon Berland; Jean-Pierre Gorvel; Patricia Renesto
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  24 in total

Review 1.  A red herring in vascular calcification: 'nanobacteria' are protein-mineral complexes involved in biomineralization.

Authors:  Georg Schlieper; Thilo Krüger; Alexander Heiss; Willi Jahnen-Dechent
Journal:  Nephrol Dial Transplant       Date:  2011-09-29       Impact factor: 5.992

2.  Critical evaluation of gamma-irradiated serum used as feeder in the culture and demonstration of putative nanobacteria and calcifying nanoparticles.

Authors:  Jan Martel; Cheng-Yeu Wu; John D Young
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

3.  Membrane vesicles nucleate mineralo-organic nanoparticles and induce carbonate apatite precipitation in human body fluids.

Authors:  Cheng-Yeu Wu; Jan Martel; Wei-Yun Cheng; Chao-Chih He; David M Ojcius; John D Young
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 4.  The role of fetuin-A in mineral trafficking and deposition.

Authors:  Michael M X Cai; Edward R Smith; Stephen G Holt
Journal:  Bonekey Rep       Date:  2015-05-06

5.  Nanoparticle-based test measures overall propensity for calcification in serum.

Authors:  Andreas Pasch; Stefan Farese; Steffen Gräber; Johanna Wald; Walter Richtering; Jürgen Floege; Willi Jahnen-Dechent
Journal:  J Am Soc Nephrol       Date:  2012-09-06       Impact factor: 10.121

6.  Protein-bound calcium phosphate in uremic rat serum: a quantitative study.

Authors:  Hong-Xing Fan; Bao-Di Gou; Yu-Xi Gao; Gang Wu; Shu-Hu Liu; Fan Li; Tian-Lan Zhang
Journal:  J Biol Inorg Chem       Date:  2020-08-24       Impact factor: 3.358

Review 7.  Anti-inflammatory role of fetuin-A in injury and infection.

Authors:  H Wang; A E Sama
Journal:  Curr Mol Med       Date:  2012-06       Impact factor: 2.222

Review 8.  Microvesicles at the crossroads between infection and cardiovascular diseases.

Authors:  Jing Xiong; Virginia M Miller; Yunman Li; Muthuvel Jayachandran
Journal:  J Cardiovasc Pharmacol       Date:  2012-02       Impact factor: 3.105

9.  Key role of alkaline phosphatase in the development of human-derived nanoparticles in vitro.

Authors:  Larry W Hunter; Farooq A Shiekh; George T Pisimisis; Sung-Hoon Kim; Samuel N Edeh; Virginia M Miller; John C Lieske
Journal:  Acta Biomater       Date:  2010-10-26       Impact factor: 8.947

10.  Accelerated growth plate mineralization and foreshortened proximal limb bones in fetuin-A knockout mice.

Authors:  Jong Seto; Björn Busse; Himadri S Gupta; Cora Schäfer; Stefanie Krauss; John W C Dunlop; Admir Masic; Michael Kerschnitzki; Paul Zaslansky; Peter Boesecke; Philip Catalá-Lehnen; Thorsten Schinke; Peter Fratzl; Willi Jahnen-Dechent
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.